^“Human caveolin-1 and caveolin-2 are closely linked genes colocalized with WI-5336 in a region of 7q31 frequently deleted in tumors”. Genomics56 (3): 355–6. (March 1999). doi:10.1006/geno.1998.5723. PMID10087206.
^“Evidence for a regulated interaction between heterotrimeric G proteins and caveolin”. The Journal of Biological Chemistry270 (26): 15693–701. (June 1995). doi:10.1074/jbc.270.26.15693. PMID7797570.
^“Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes”. The Journal of Biological Chemistry271 (1): 568–73. (January 1996). doi:10.1074/jbc.271.1.568. PMID8550621.
^“Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor”. The Journal of Biological Chemistry276 (9): 6727–38. (March 2001). doi:10.1074/jbc.M008340200. PMID11102446.
^“Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1”. The Journal of Biological Chemistry271 (44): 27237–40. (November 1996). doi:10.1074/jbc.271.44.27237. PMID8910295.
^“Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation”. The Journal of Biological Chemistry276 (16): 13442–51. (April 2001). doi:10.1074/jbc.M006598200. PMID11278309.
^“Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein”. The Journal of Biological Chemistry273 (17): 10485–95. (April 1998). doi:10.1074/jbc.273.17.10485. PMID9553108.
^“Connexin family members target to lipid raft domains and interact with caveolin-1”. Biochemistry41 (18): 5754–64. (May 2002). doi:10.1021/bi0121656. PMID11980479.
^“Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities”. The Journal of Biological Chemistry272 (48): 30429–38. (November 1997). doi:10.1074/jbc.272.48.30429. PMID9374534.
^ ab“Caveolin is an inhibitor of platelet-derived growth factor receptor signaling”. Experimental Cell Research247 (2): 380–8. (March 1999). doi:10.1006/excr.1998.4379. PMID10066366.
^“Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts”. The Journal of Biological Chemistry276 (37): 34975–82. (September 2001). doi:10.1074/jbc.M105946200. PMID11432874.
^“Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors”. The Journal of Biological Chemistry276 (11): 8341–9. (March 2001). doi:10.1074/jbc.M007116200. PMID11112773.
^“A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase”. The Journal of Biological Chemistry277 (11): 8771–4. (March 2002). doi:10.1074/jbc.C100661200. PMID11805080.
^“The scaffolding domain of caveolin 2 is responsible for its Golgi localization in Caco-2 cells”. Journal of Cell Science115 (Pt 23): 4457–67. (December 2002). doi:10.1242/jcs.00130. PMID12414992.
^“Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo”. The Journal of Biological Chemistry272 (46): 29337–46. (November 1997). doi:10.1074/jbc.272.46.29337. PMID9361015.
^“Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation”. The Journal of Investigative Dermatology121 (6): 1487–95. (December 2003). doi:10.1111/j.1523-1747.2003.12614.x. PMID14675200.
^“Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains”. FEBS Letters467 (2–3): 326–32. (February 2000). doi:10.1016/S0014-5793(00)01174-1. PMID10675563.
^“Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx”. The Journal of Biological Chemistry277 (11): 9351–7. (March 2002). doi:10.1074/jbc.M108537200. PMID11751885.
^“Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins”. The Journal of Biological Chemistry272 (10): 6525–33. (March 1997). doi:10.1074/jbc.272.10.6525. PMID9045678.
“Caveolin-1 and cancer multidrug resistance: coordinate regulation of pro-survival proteins?”. Leukemia Research28 (9): 907–8. (September 2004). doi:10.1016/j.leukres.2004.03.013. PMID15234566.
“Caveolin-1 and liver regeneration: role in proliferation and lipogenesis”. Cell Cycle6 (2): 115–6. (January 2007). doi:10.4161/cc.6.2.3722. PMID17314510.